. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Controlled Clinical Trials as TopicCoronary Disease/epidemiologyCosts and Cost AnalysisDietary Fats, Unsaturated/therapeutic useDocosahexaenoic Acids/adverse effectsDocosahexaenoic Acids/therapeutic useDose-Response Relationship, DrugDrug CombinationsDrug InteractionsDyspepsia/chemically inducedEicosapentaenoic Acid/adverse effectsEicosapentaenoic Acid/therapeutic useFatty Acids, Omega-3/economicsFatty Acids, Omega-3/therapeutic useFatty Acids, Unsaturated/economicsFatty Acids, Unsaturated/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyHypertriglyceridemia/diet therapyHypertriglyceridemia/drug therapy
Substances： See more » Dietary Fats, UnsaturatedDrug CombinationsFatty Acids, Omega-3Fatty Acids, UnsaturatedHydroxymethylglutaryl-CoA Reductase InhibitorsDocosahexaenoic AcidsEicosapentaenoic AcidOmacor
Year: 2005 PMID： 16267495
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909